Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
SOUTH KOREA – Samsung Biologics has completed the US$2.3 billion acquisition of Biogen’s stake in the Samsung Bioepis joint venture. Samsung Biologics signed a stake acquisition agreement in January of…
Read More
SOUTH KOREA – Samsung Biologics announced that it has agreed to pay US$2.3 billion for Biogen’s stake in their nearly decade-long biosimilars joint venture Samsung Bioepis. The announcement follows a…
Read More
USA – To meet rising demand, GlaxoSmithKline and partner Vir Biotechnology are increasing output of their COVID-19 antibody treatment sotrovimab at a second plant. The supply crunch is exacerbated further…
Read More
SOUTH KOREA – Samsung Biologics, a major South Korean contract drug manufacturer, has rolled out supplies of the first batch of domestically-made Moderna vaccines. Moderna’s COVID-19 vaccine, manufactured by Samsung…
Read More